… According to rapid development of chemotherapy in advanced non-small cell lung cancer
(NSCLC), the Japan Lung Cancer Society has been updated its own guideline annually since …

… The JO25567 study was a randomised, multicentre, phase 2 trial that compared
bevacizumab–erlotinib with erlotinib alone as first-line treatments in 154 Japanese patients with …

… This study demonstrates improved surgical results for lung cancer in Japan. The TNM
revision for the eighth edition was supported by the assessment of stage migration from the …

… The expression levels of PD-L1 were not routinely assayed in the present study because no
diagnostic kits were commercially available in Japan at the time. Therefore, we were unable …

… 13,951 patients with nonsquamous non-small cell lung cancer included in this study, 5780
patients (… in a large cohort of Japanese patients with surgically treated lung adenocarcinoma …

… -stage lung cancer is only indicated for selected patients with … 90s in Japan, the early detection
of small-sized early lung … is a highly malignant disease, according to our results, patients …

… The J-ALEX study compared the efficacy and safety of alectinib with crizotinib in Japanese
patients with advanced ALK-positive non-small-cell lung cancer (NSCLC). Superiority in …

… Our Japan-specific trial may limit the generalizability of the results, since all enrolled
participants are Japanese patients with NSCLC who usually show better survival than Western …

… in Japanese patients diagnosed with major solid tumors. Methods: To obtain patient-level …
population-based cancer registry data from Osaka Prefecture, Japan and administrative data …

… To select lung cancer that has no nodal involvement or lymphovascular invasion, the Japan
… The study defined radiologic noninvasive lung cancer as lung cancer 2 cm or less in size …